No­var­tis re­ports two pa­tient deaths af­ter treat­ment with Zol­gens­ma

Two chil­dren with spinal mus­cu­lar at­ro­phy have died af­ter re­ceiv­ing No­var­tis’ Zol­gens­ma, a gene ther­a­py de­signed as a one-time treat­ment for the rare fa­tal dis­ease …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER